Birchview Capital, LP Arvinas, Inc. Transaction History
Birchview Capital, LP
- $108 Million
- Q3 2024
A detailed history of Birchview Capital, LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 15,000 shares of ARVN stock, worth $307,500. This represents 0.34% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$307,500
Previous $399,000
7.52%
% of portfolio
0.34%
Previous 0.4%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
230Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$144 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$138 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$128 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$79 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$57 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.09B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...